Physical and Engineering Sciences in Oncology
Page 2

a) The development of novel non-traditional physical and engineering sciences based approaches, materials, or platforms to thoroughly comprehend cancer disorders.

b) The generation of unique sets of physical measurements that are capable of providing insight into molecular mechanisms of oncogenesis, metastasis, drug resistance or other aspects of cancer that could potentially lead to a more effective treatment of the disease.

c) The development and evaluation of theoretical approaches that would provide a comprehensive and dynamic understanding of cancer disorders.

The NSF estimates that it would award 5 to 10 grants to different applicants, with each grant amounting to $2,000,000 to $3,000,000.

The institutions and organizations that will be considered eligible to submit an application for the Physical and Engineering Sciences in Oncology Program are the following:

a) Universities and two- and four-year colleges including community colleges that are located in the United States

b) Non-profit, non-academic organizations such as Independent museums, observatories, research laboratories and professional societies

c) For-profit organizations

d) State, Local, City and Township Governments

e) Unaffiliated Individuals such as Scientists, engineers or educators

f) Foreign organizations

g) Other Federal agencies.


Physical and Engineering Sciences in Oncology
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on community grants and health grants.

Additional Resources

category - Health Grants

Medical Tropical Research Laboratory Program Infectious Disease Research Award
AFRIMS has recently announced the WRAIR Medical Tropical Research Laboratory Program(MTRLP) Infectious Disease Research Award(IDRA), a funding opportunity which solicits proposals that aim to tackle basic, preclinical and clinical research of emerging infectious diseases in Thailand and a certain region in Southeast Asia.

---

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---